PNNL has created and licensed a system that sniffs out trace levels of fentanyl, other drugs and explosives through the air.

Researchers at PNNL are pursuing new approaches to understand, predict and control the phenome—the collection of biological traits within an organism shaped by its genes and interactions with the environment.

PNNL's accomplishments in FY 2024 help address the remaining challenges the wind industry faces.

Scientists are developing ways to detect previously unseen forms of fentanyl as well as other synthetic opioids known as nitazenes.

A cross-institutional team of scientists developed PeakQC, a new software tool for automated quality control of mass spectrometry data.

With the launch of a large research barge, PNNL and collaborators took another significant step to improve offshore wind forecasting that will lower risk and cost associated with offshore wind energy development.

Ljiljana Paša-Tolić, a PNNL fellow, is the recipient of the 2024 International Mass Spectrometry Foundation’s Jochen Franzen Award. 

Scientists have developed a way to detect tiny amounts of hard-to-detect explosives more than eight feet away.

A team of researchers from Pacific Northwest National Laboratory and the Environmental Molecular Sciences Laboratory developed a new and flexible software tool called “Advanced Spectra PCA Toolbox.”

Vigorous exercise burns fat more in males than in females, but the benefits of exercise are broad for both sexes.

Three PNNL-affiliated researchers have been named fellows of the American Association for the Advancement of Science, the world’s largest multidisciplinary scientific society.

Researchers seek to bring down costs, address potential environmental risks and maximize the benefits of harnessing wind energy above the deep waters of the Pacific.

Scientists have learned more about how to protect the insulin-producing cells that die in patients with Type 1 diabetes.

The nation is closer to its offshore wind energy goals than ever before, but better wind forecasting is still needed. To address this challenge, PNNL and collaborators are charting a new course with help from novel technology.

PNNL researchers helped identify a fragment from the SARS-CoV-2 virus that spurs severe illness.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

PNNL had a significant presence at October’s North American Wind Energy Academy/WindTech 2023 Conference in Denver, Colorado. Thirteen PNNL wind experts participated in various capacities.

PNNL scientists took thousands of measurements of firefighters in training to learn more about how the body responds to vigorous exercise.

Floating offshore wind farms could potentially triple the Pacific Northwest's wind power capacity while offsetting billions of dollars in costs for utilities, ratepayers, insurance companies, and others.

Scientists have opened a new view into the workings of the central nervous system, finding a diverse set of important molecules.